Global GLP-1 Drug Peptide API Supply, Demand and Key Producers, 2023-2029
The global GLP-1 Drug Peptide API market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
GLP-1 (Glucagon-Like Peptide-1) drugs are a class of drugs used to treat type 2 diabetes and obesity, usually prepared in the form of polypeptides. These drugs mimic the GLP-1 hormone in the body, causing the release of insulin and controlling blood sugar levels. Peptide APIs are the starting components of these drugs, typically synthesized or produced in laboratories and used in further formulation preparations.
This report studies the global GLP-1 Drug Peptide API production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for GLP-1 Drug Peptide API, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of GLP-1 Drug Peptide API that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global GLP-1 Drug Peptide API total production and demand, 2018-2029, (Tons)
Global GLP-1 Drug Peptide API total production value, 2018-2029, (USD Million)
Global GLP-1 Drug Peptide API production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (Tons)
Global GLP-1 Drug Peptide API consumption by region & country, CAGR, 2018-2029 & (Tons)
U.S. VS China: GLP-1 Drug Peptide API domestic production, consumption, key domestic manufacturers and share
Global GLP-1 Drug Peptide API production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (Tons)
Global GLP-1 Drug Peptide API production by Type, production, value, CAGR, 2018-2029, (USD Million) & (Tons)
Global GLP-1 Drug Peptide API production by Application production, value, CAGR, 2018-2029, (USD Million) & (Tons).
This reports profiles key players in the global GLP-1 Drug Peptide API market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CPC Scientific, Novo Nordisk, Teva Pharmaceutical Industries Ltd, JYMedtech, Zhejiang Peptites Biotech, Shengnuo Biotechnology, Suzhou Tianma Pharmaceutical, SINOPEP and WuXi AppTec, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World GLP-1 Drug Peptide API market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Ton) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global GLP-1 Drug Peptide API Market, By Region:
1. How big is the global GLP-1 Drug Peptide API market?
2. What is the demand of the global GLP-1 Drug Peptide API market?
3. What is the year over year growth of the global GLP-1 Drug Peptide API market?
4. What is the production and production value of the global GLP-1 Drug Peptide API market?
5. Who are the key producers in the global GLP-1 Drug Peptide API market?
GLP-1 (Glucagon-Like Peptide-1) drugs are a class of drugs used to treat type 2 diabetes and obesity, usually prepared in the form of polypeptides. These drugs mimic the GLP-1 hormone in the body, causing the release of insulin and controlling blood sugar levels. Peptide APIs are the starting components of these drugs, typically synthesized or produced in laboratories and used in further formulation preparations.
This report studies the global GLP-1 Drug Peptide API production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for GLP-1 Drug Peptide API, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of GLP-1 Drug Peptide API that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global GLP-1 Drug Peptide API total production and demand, 2018-2029, (Tons)
Global GLP-1 Drug Peptide API total production value, 2018-2029, (USD Million)
Global GLP-1 Drug Peptide API production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (Tons)
Global GLP-1 Drug Peptide API consumption by region & country, CAGR, 2018-2029 & (Tons)
U.S. VS China: GLP-1 Drug Peptide API domestic production, consumption, key domestic manufacturers and share
Global GLP-1 Drug Peptide API production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (Tons)
Global GLP-1 Drug Peptide API production by Type, production, value, CAGR, 2018-2029, (USD Million) & (Tons)
Global GLP-1 Drug Peptide API production by Application production, value, CAGR, 2018-2029, (USD Million) & (Tons).
This reports profiles key players in the global GLP-1 Drug Peptide API market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CPC Scientific, Novo Nordisk, Teva Pharmaceutical Industries Ltd, JYMedtech, Zhejiang Peptites Biotech, Shengnuo Biotechnology, Suzhou Tianma Pharmaceutical, SINOPEP and WuXi AppTec, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World GLP-1 Drug Peptide API market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Ton) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global GLP-1 Drug Peptide API Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Semaglutide
- Liraglutide
- Tilpotide
- Diabetes
- Obesity
- Other
- CPC Scientific
- Novo Nordisk
- Teva Pharmaceutical Industries Ltd
- JYMedtech
- Zhejiang Peptites Biotech
- Shengnuo Biotechnology
- Suzhou Tianma Pharmaceutical
- SINOPEP
- WuXi AppTec
- HYBIO Pharmaceutical
1. How big is the global GLP-1 Drug Peptide API market?
2. What is the demand of the global GLP-1 Drug Peptide API market?
3. What is the year over year growth of the global GLP-1 Drug Peptide API market?
4. What is the production and production value of the global GLP-1 Drug Peptide API market?
5. Who are the key producers in the global GLP-1 Drug Peptide API market?
1 SUPPLY SUMMARY
1.1 GLP-1 Drug Peptide API Introduction
1.2 World GLP-1 Drug Peptide API Supply & Forecast
1.2.1 World GLP-1 Drug Peptide API Production Value (2018 & 2022 & 2029)
1.2.2 World GLP-1 Drug Peptide API Production (2018-2029)
1.2.3 World GLP-1 Drug Peptide API Pricing Trends (2018-2029)
1.3 World GLP-1 Drug Peptide API Production by Region (Based on Production Site)
1.3.1 World GLP-1 Drug Peptide API Production Value by Region (2018-2029)
1.3.2 World GLP-1 Drug Peptide API Production by Region (2018-2029)
1.3.3 World GLP-1 Drug Peptide API Average Price by Region (2018-2029)
1.3.4 North America GLP-1 Drug Peptide API Production (2018-2029)
1.3.5 Europe GLP-1 Drug Peptide API Production (2018-2029)
1.3.6 China GLP-1 Drug Peptide API Production (2018-2029)
1.3.7 Japan GLP-1 Drug Peptide API Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 GLP-1 Drug Peptide API Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 GLP-1 Drug Peptide API Major Market Trends
2 DEMAND SUMMARY
2.1 World GLP-1 Drug Peptide API Demand (2018-2029)
2.2 World GLP-1 Drug Peptide API Consumption by Region
2.2.1 World GLP-1 Drug Peptide API Consumption by Region (2018-2023)
2.2.2 World GLP-1 Drug Peptide API Consumption Forecast by Region (2024-2029)
2.3 United States GLP-1 Drug Peptide API Consumption (2018-2029)
2.4 China GLP-1 Drug Peptide API Consumption (2018-2029)
2.5 Europe GLP-1 Drug Peptide API Consumption (2018-2029)
2.6 Japan GLP-1 Drug Peptide API Consumption (2018-2029)
2.7 South Korea GLP-1 Drug Peptide API Consumption (2018-2029)
2.8 ASEAN GLP-1 Drug Peptide API Consumption (2018-2029)
2.9 India GLP-1 Drug Peptide API Consumption (2018-2029)
3 WORLD GLP-1 DRUG PEPTIDE API MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World GLP-1 Drug Peptide API Production Value by Manufacturer (2018-2023)
3.2 World GLP-1 Drug Peptide API Production by Manufacturer (2018-2023)
3.3 World GLP-1 Drug Peptide API Average Price by Manufacturer (2018-2023)
3.4 GLP-1 Drug Peptide API Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global GLP-1 Drug Peptide API Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for GLP-1 Drug Peptide API in 2022
3.5.3 Global Concentration Ratios (CR8) for GLP-1 Drug Peptide API in 2022
3.6 GLP-1 Drug Peptide API Market: Overall Company Footprint Analysis
3.6.1 GLP-1 Drug Peptide API Market: Region Footprint
3.6.2 GLP-1 Drug Peptide API Market: Company Product Type Footprint
3.6.3 GLP-1 Drug Peptide API Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: GLP-1 Drug Peptide API Production Value Comparison
4.1.1 United States VS China: GLP-1 Drug Peptide API Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: GLP-1 Drug Peptide API Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: GLP-1 Drug Peptide API Production Comparison
4.2.1 United States VS China: GLP-1 Drug Peptide API Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: GLP-1 Drug Peptide API Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: GLP-1 Drug Peptide API Consumption Comparison
4.3.1 United States VS China: GLP-1 Drug Peptide API Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: GLP-1 Drug Peptide API Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based GLP-1 Drug Peptide API Manufacturers and Market Share, 2018-2023
4.4.1 United States Based GLP-1 Drug Peptide API Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers GLP-1 Drug Peptide API Production Value (2018-2023)
4.4.3 United States Based Manufacturers GLP-1 Drug Peptide API Production (2018-2023)
4.5 China Based GLP-1 Drug Peptide API Manufacturers and Market Share
4.5.1 China Based GLP-1 Drug Peptide API Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers GLP-1 Drug Peptide API Production Value (2018-2023)
4.5.3 China Based Manufacturers GLP-1 Drug Peptide API Production (2018-2023)
4.6 Rest of World Based GLP-1 Drug Peptide API Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based GLP-1 Drug Peptide API Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers GLP-1 Drug Peptide API Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers GLP-1 Drug Peptide API Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World GLP-1 Drug Peptide API Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Semaglutide
5.2.2 Liraglutide
5.2.3 Tilpotide
5.3 Market Segment by Type
5.3.1 World GLP-1 Drug Peptide API Production by Type (2018-2029)
5.3.2 World GLP-1 Drug Peptide API Production Value by Type (2018-2029)
5.3.3 World GLP-1 Drug Peptide API Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World GLP-1 Drug Peptide API Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Diabetes
6.2.2 Obesity
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World GLP-1 Drug Peptide API Production by Application (2018-2029)
6.3.2 World GLP-1 Drug Peptide API Production Value by Application (2018-2029)
6.3.3 World GLP-1 Drug Peptide API Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 CPC Scientific
7.1.1 CPC Scientific Details
7.1.2 CPC Scientific Major Business
7.1.3 CPC Scientific GLP-1 Drug Peptide API Product and Services
7.1.4 CPC Scientific GLP-1 Drug Peptide API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 CPC Scientific Recent Developments/Updates
7.1.6 CPC Scientific Competitive Strengths & Weaknesses
7.2 Novo Nordisk
7.2.1 Novo Nordisk Details
7.2.2 Novo Nordisk Major Business
7.2.3 Novo Nordisk GLP-1 Drug Peptide API Product and Services
7.2.4 Novo Nordisk GLP-1 Drug Peptide API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Novo Nordisk Recent Developments/Updates
7.2.6 Novo Nordisk Competitive Strengths & Weaknesses
7.3 Teva Pharmaceutical Industries Ltd
7.3.1 Teva Pharmaceutical Industries Ltd Details
7.3.2 Teva Pharmaceutical Industries Ltd Major Business
7.3.3 Teva Pharmaceutical Industries Ltd GLP-1 Drug Peptide API Product and Services
7.3.4 Teva Pharmaceutical Industries Ltd GLP-1 Drug Peptide API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.3.6 Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.4 JYMedtech
7.4.1 JYMedtech Details
7.4.2 JYMedtech Major Business
7.4.3 JYMedtech GLP-1 Drug Peptide API Product and Services
7.4.4 JYMedtech GLP-1 Drug Peptide API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 JYMedtech Recent Developments/Updates
7.4.6 JYMedtech Competitive Strengths & Weaknesses
7.5 Zhejiang Peptites Biotech
7.5.1 Zhejiang Peptites Biotech Details
7.5.2 Zhejiang Peptites Biotech Major Business
7.5.3 Zhejiang Peptites Biotech GLP-1 Drug Peptide API Product and Services
7.5.4 Zhejiang Peptites Biotech GLP-1 Drug Peptide API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Zhejiang Peptites Biotech Recent Developments/Updates
7.5.6 Zhejiang Peptites Biotech Competitive Strengths & Weaknesses
7.6 Shengnuo Biotechnology
7.6.1 Shengnuo Biotechnology Details
7.6.2 Shengnuo Biotechnology Major Business
7.6.3 Shengnuo Biotechnology GLP-1 Drug Peptide API Product and Services
7.6.4 Shengnuo Biotechnology GLP-1 Drug Peptide API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Shengnuo Biotechnology Recent Developments/Updates
7.6.6 Shengnuo Biotechnology Competitive Strengths & Weaknesses
7.7 Suzhou Tianma Pharmaceutical
7.7.1 Suzhou Tianma Pharmaceutical Details
7.7.2 Suzhou Tianma Pharmaceutical Major Business
7.7.3 Suzhou Tianma Pharmaceutical GLP-1 Drug Peptide API Product and Services
7.7.4 Suzhou Tianma Pharmaceutical GLP-1 Drug Peptide API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Suzhou Tianma Pharmaceutical Recent Developments/Updates
7.7.6 Suzhou Tianma Pharmaceutical Competitive Strengths & Weaknesses
7.8 SINOPEP
7.8.1 SINOPEP Details
7.8.2 SINOPEP Major Business
7.8.3 SINOPEP GLP-1 Drug Peptide API Product and Services
7.8.4 SINOPEP GLP-1 Drug Peptide API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 SINOPEP Recent Developments/Updates
7.8.6 SINOPEP Competitive Strengths & Weaknesses
7.9 WuXi AppTec
7.9.1 WuXi AppTec Details
7.9.2 WuXi AppTec Major Business
7.9.3 WuXi AppTec GLP-1 Drug Peptide API Product and Services
7.9.4 WuXi AppTec GLP-1 Drug Peptide API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 WuXi AppTec Recent Developments/Updates
7.9.6 WuXi AppTec Competitive Strengths & Weaknesses
7.10 HYBIO Pharmaceutical
7.10.1 HYBIO Pharmaceutical Details
7.10.2 HYBIO Pharmaceutical Major Business
7.10.3 HYBIO Pharmaceutical GLP-1 Drug Peptide API Product and Services
7.10.4 HYBIO Pharmaceutical GLP-1 Drug Peptide API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 HYBIO Pharmaceutical Recent Developments/Updates
7.10.6 HYBIO Pharmaceutical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 GLP-1 Drug Peptide API Industry Chain
8.2 GLP-1 Drug Peptide API Upstream Analysis
8.2.1 GLP-1 Drug Peptide API Core Raw Materials
8.2.2 Main Manufacturers of GLP-1 Drug Peptide API Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 GLP-1 Drug Peptide API Production Mode
8.6 GLP-1 Drug Peptide API Procurement Model
8.7 GLP-1 Drug Peptide API Industry Sales Model and Sales Channels
8.7.1 GLP-1 Drug Peptide API Sales Model
8.7.2 GLP-1 Drug Peptide API Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 GLP-1 Drug Peptide API Introduction
1.2 World GLP-1 Drug Peptide API Supply & Forecast
1.2.1 World GLP-1 Drug Peptide API Production Value (2018 & 2022 & 2029)
1.2.2 World GLP-1 Drug Peptide API Production (2018-2029)
1.2.3 World GLP-1 Drug Peptide API Pricing Trends (2018-2029)
1.3 World GLP-1 Drug Peptide API Production by Region (Based on Production Site)
1.3.1 World GLP-1 Drug Peptide API Production Value by Region (2018-2029)
1.3.2 World GLP-1 Drug Peptide API Production by Region (2018-2029)
1.3.3 World GLP-1 Drug Peptide API Average Price by Region (2018-2029)
1.3.4 North America GLP-1 Drug Peptide API Production (2018-2029)
1.3.5 Europe GLP-1 Drug Peptide API Production (2018-2029)
1.3.6 China GLP-1 Drug Peptide API Production (2018-2029)
1.3.7 Japan GLP-1 Drug Peptide API Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 GLP-1 Drug Peptide API Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 GLP-1 Drug Peptide API Major Market Trends
2 DEMAND SUMMARY
2.1 World GLP-1 Drug Peptide API Demand (2018-2029)
2.2 World GLP-1 Drug Peptide API Consumption by Region
2.2.1 World GLP-1 Drug Peptide API Consumption by Region (2018-2023)
2.2.2 World GLP-1 Drug Peptide API Consumption Forecast by Region (2024-2029)
2.3 United States GLP-1 Drug Peptide API Consumption (2018-2029)
2.4 China GLP-1 Drug Peptide API Consumption (2018-2029)
2.5 Europe GLP-1 Drug Peptide API Consumption (2018-2029)
2.6 Japan GLP-1 Drug Peptide API Consumption (2018-2029)
2.7 South Korea GLP-1 Drug Peptide API Consumption (2018-2029)
2.8 ASEAN GLP-1 Drug Peptide API Consumption (2018-2029)
2.9 India GLP-1 Drug Peptide API Consumption (2018-2029)
3 WORLD GLP-1 DRUG PEPTIDE API MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World GLP-1 Drug Peptide API Production Value by Manufacturer (2018-2023)
3.2 World GLP-1 Drug Peptide API Production by Manufacturer (2018-2023)
3.3 World GLP-1 Drug Peptide API Average Price by Manufacturer (2018-2023)
3.4 GLP-1 Drug Peptide API Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global GLP-1 Drug Peptide API Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for GLP-1 Drug Peptide API in 2022
3.5.3 Global Concentration Ratios (CR8) for GLP-1 Drug Peptide API in 2022
3.6 GLP-1 Drug Peptide API Market: Overall Company Footprint Analysis
3.6.1 GLP-1 Drug Peptide API Market: Region Footprint
3.6.2 GLP-1 Drug Peptide API Market: Company Product Type Footprint
3.6.3 GLP-1 Drug Peptide API Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: GLP-1 Drug Peptide API Production Value Comparison
4.1.1 United States VS China: GLP-1 Drug Peptide API Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: GLP-1 Drug Peptide API Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: GLP-1 Drug Peptide API Production Comparison
4.2.1 United States VS China: GLP-1 Drug Peptide API Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: GLP-1 Drug Peptide API Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: GLP-1 Drug Peptide API Consumption Comparison
4.3.1 United States VS China: GLP-1 Drug Peptide API Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: GLP-1 Drug Peptide API Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based GLP-1 Drug Peptide API Manufacturers and Market Share, 2018-2023
4.4.1 United States Based GLP-1 Drug Peptide API Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers GLP-1 Drug Peptide API Production Value (2018-2023)
4.4.3 United States Based Manufacturers GLP-1 Drug Peptide API Production (2018-2023)
4.5 China Based GLP-1 Drug Peptide API Manufacturers and Market Share
4.5.1 China Based GLP-1 Drug Peptide API Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers GLP-1 Drug Peptide API Production Value (2018-2023)
4.5.3 China Based Manufacturers GLP-1 Drug Peptide API Production (2018-2023)
4.6 Rest of World Based GLP-1 Drug Peptide API Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based GLP-1 Drug Peptide API Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers GLP-1 Drug Peptide API Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers GLP-1 Drug Peptide API Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World GLP-1 Drug Peptide API Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Semaglutide
5.2.2 Liraglutide
5.2.3 Tilpotide
5.3 Market Segment by Type
5.3.1 World GLP-1 Drug Peptide API Production by Type (2018-2029)
5.3.2 World GLP-1 Drug Peptide API Production Value by Type (2018-2029)
5.3.3 World GLP-1 Drug Peptide API Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World GLP-1 Drug Peptide API Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Diabetes
6.2.2 Obesity
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World GLP-1 Drug Peptide API Production by Application (2018-2029)
6.3.2 World GLP-1 Drug Peptide API Production Value by Application (2018-2029)
6.3.3 World GLP-1 Drug Peptide API Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 CPC Scientific
7.1.1 CPC Scientific Details
7.1.2 CPC Scientific Major Business
7.1.3 CPC Scientific GLP-1 Drug Peptide API Product and Services
7.1.4 CPC Scientific GLP-1 Drug Peptide API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 CPC Scientific Recent Developments/Updates
7.1.6 CPC Scientific Competitive Strengths & Weaknesses
7.2 Novo Nordisk
7.2.1 Novo Nordisk Details
7.2.2 Novo Nordisk Major Business
7.2.3 Novo Nordisk GLP-1 Drug Peptide API Product and Services
7.2.4 Novo Nordisk GLP-1 Drug Peptide API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Novo Nordisk Recent Developments/Updates
7.2.6 Novo Nordisk Competitive Strengths & Weaknesses
7.3 Teva Pharmaceutical Industries Ltd
7.3.1 Teva Pharmaceutical Industries Ltd Details
7.3.2 Teva Pharmaceutical Industries Ltd Major Business
7.3.3 Teva Pharmaceutical Industries Ltd GLP-1 Drug Peptide API Product and Services
7.3.4 Teva Pharmaceutical Industries Ltd GLP-1 Drug Peptide API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.3.6 Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.4 JYMedtech
7.4.1 JYMedtech Details
7.4.2 JYMedtech Major Business
7.4.3 JYMedtech GLP-1 Drug Peptide API Product and Services
7.4.4 JYMedtech GLP-1 Drug Peptide API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 JYMedtech Recent Developments/Updates
7.4.6 JYMedtech Competitive Strengths & Weaknesses
7.5 Zhejiang Peptites Biotech
7.5.1 Zhejiang Peptites Biotech Details
7.5.2 Zhejiang Peptites Biotech Major Business
7.5.3 Zhejiang Peptites Biotech GLP-1 Drug Peptide API Product and Services
7.5.4 Zhejiang Peptites Biotech GLP-1 Drug Peptide API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Zhejiang Peptites Biotech Recent Developments/Updates
7.5.6 Zhejiang Peptites Biotech Competitive Strengths & Weaknesses
7.6 Shengnuo Biotechnology
7.6.1 Shengnuo Biotechnology Details
7.6.2 Shengnuo Biotechnology Major Business
7.6.3 Shengnuo Biotechnology GLP-1 Drug Peptide API Product and Services
7.6.4 Shengnuo Biotechnology GLP-1 Drug Peptide API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Shengnuo Biotechnology Recent Developments/Updates
7.6.6 Shengnuo Biotechnology Competitive Strengths & Weaknesses
7.7 Suzhou Tianma Pharmaceutical
7.7.1 Suzhou Tianma Pharmaceutical Details
7.7.2 Suzhou Tianma Pharmaceutical Major Business
7.7.3 Suzhou Tianma Pharmaceutical GLP-1 Drug Peptide API Product and Services
7.7.4 Suzhou Tianma Pharmaceutical GLP-1 Drug Peptide API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Suzhou Tianma Pharmaceutical Recent Developments/Updates
7.7.6 Suzhou Tianma Pharmaceutical Competitive Strengths & Weaknesses
7.8 SINOPEP
7.8.1 SINOPEP Details
7.8.2 SINOPEP Major Business
7.8.3 SINOPEP GLP-1 Drug Peptide API Product and Services
7.8.4 SINOPEP GLP-1 Drug Peptide API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 SINOPEP Recent Developments/Updates
7.8.6 SINOPEP Competitive Strengths & Weaknesses
7.9 WuXi AppTec
7.9.1 WuXi AppTec Details
7.9.2 WuXi AppTec Major Business
7.9.3 WuXi AppTec GLP-1 Drug Peptide API Product and Services
7.9.4 WuXi AppTec GLP-1 Drug Peptide API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 WuXi AppTec Recent Developments/Updates
7.9.6 WuXi AppTec Competitive Strengths & Weaknesses
7.10 HYBIO Pharmaceutical
7.10.1 HYBIO Pharmaceutical Details
7.10.2 HYBIO Pharmaceutical Major Business
7.10.3 HYBIO Pharmaceutical GLP-1 Drug Peptide API Product and Services
7.10.4 HYBIO Pharmaceutical GLP-1 Drug Peptide API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 HYBIO Pharmaceutical Recent Developments/Updates
7.10.6 HYBIO Pharmaceutical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 GLP-1 Drug Peptide API Industry Chain
8.2 GLP-1 Drug Peptide API Upstream Analysis
8.2.1 GLP-1 Drug Peptide API Core Raw Materials
8.2.2 Main Manufacturers of GLP-1 Drug Peptide API Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 GLP-1 Drug Peptide API Production Mode
8.6 GLP-1 Drug Peptide API Procurement Model
8.7 GLP-1 Drug Peptide API Industry Sales Model and Sales Channels
8.7.1 GLP-1 Drug Peptide API Sales Model
8.7.2 GLP-1 Drug Peptide API Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World GLP-1 Drug Peptide API Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World GLP-1 Drug Peptide API Production Value by Region (2018-2023) & (USD Million)
Table 3. World GLP-1 Drug Peptide API Production Value by Region (2024-2029) & (USD Million)
Table 4. World GLP-1 Drug Peptide API Production Value Market Share by Region (2018-2023)
Table 5. World GLP-1 Drug Peptide API Production Value Market Share by Region (2024-2029)
Table 6. World GLP-1 Drug Peptide API Production by Region (2018-2023) & (Tons)
Table 7. World GLP-1 Drug Peptide API Production by Region (2024-2029) & (Tons)
Table 8. World GLP-1 Drug Peptide API Production Market Share by Region (2018-2023)
Table 9. World GLP-1 Drug Peptide API Production Market Share by Region (2024-2029)
Table 10. World GLP-1 Drug Peptide API Average Price by Region (2018-2023) & (US$/Ton)
Table 11. World GLP-1 Drug Peptide API Average Price by Region (2024-2029) & (US$/Ton)
Table 12. GLP-1 Drug Peptide API Major Market Trends
Table 13. World GLP-1 Drug Peptide API Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (Tons)
Table 14. World GLP-1 Drug Peptide API Consumption by Region (2018-2023) & (Tons)
Table 15. World GLP-1 Drug Peptide API Consumption Forecast by Region (2024-2029) & (Tons)
Table 16. World GLP-1 Drug Peptide API Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key GLP-1 Drug Peptide API Producers in 2022
Table 18. World GLP-1 Drug Peptide API Production by Manufacturer (2018-2023) & (Tons)
Table 19. Production Market Share of Key GLP-1 Drug Peptide API Producers in 2022
Table 20. World GLP-1 Drug Peptide API Average Price by Manufacturer (2018-2023) & (US$/Ton)
Table 21. Global GLP-1 Drug Peptide API Company Evaluation Quadrant
Table 22. World GLP-1 Drug Peptide API Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and GLP-1 Drug Peptide API Production Site of Key Manufacturer
Table 24. GLP-1 Drug Peptide API Market: Company Product Type Footprint
Table 25. GLP-1 Drug Peptide API Market: Company Product Application Footprint
Table 26. GLP-1 Drug Peptide API Competitive Factors
Table 27. GLP-1 Drug Peptide API New Entrant and Capacity Expansion Plans
Table 28. GLP-1 Drug Peptide API Mergers & Acquisitions Activity
Table 29. United States VS China GLP-1 Drug Peptide API Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China GLP-1 Drug Peptide API Production Comparison, (2018 & 2022 & 2029) & (Tons)
Table 31. United States VS China GLP-1 Drug Peptide API Consumption Comparison, (2018 & 2022 & 2029) & (Tons)
Table 32. United States Based GLP-1 Drug Peptide API Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers GLP-1 Drug Peptide API Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers GLP-1 Drug Peptide API Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers GLP-1 Drug Peptide API Production (2018-2023) & (Tons)
Table 36. United States Based Manufacturers GLP-1 Drug Peptide API Production Market Share (2018-2023)
Table 37. China Based GLP-1 Drug Peptide API Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers GLP-1 Drug Peptide API Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers GLP-1 Drug Peptide API Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers GLP-1 Drug Peptide API Production (2018-2023) & (Tons)
Table 41. China Based Manufacturers GLP-1 Drug Peptide API Production Market Share (2018-2023)
Table 42. Rest of World Based GLP-1 Drug Peptide API Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers GLP-1 Drug Peptide API Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers GLP-1 Drug Peptide API Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers GLP-1 Drug Peptide API Production (2018-2023) & (Tons)
Table 46. Rest of World Based Manufacturers GLP-1 Drug Peptide API Production Market Share (2018-2023)
Table 47. World GLP-1 Drug Peptide API Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World GLP-1 Drug Peptide API Production by Type (2018-2023) & (Tons)
Table 49. World GLP-1 Drug Peptide API Production by Type (2024-2029) & (Tons)
Table 50. World GLP-1 Drug Peptide API Production Value by Type (2018-2023) & (USD Million)
Table 51. World GLP-1 Drug Peptide API Production Value by Type (2024-2029) & (USD Million)
Table 52. World GLP-1 Drug Peptide API Average Price by Type (2018-2023) & (US$/Ton)
Table 53. World GLP-1 Drug Peptide API Average Price by Type (2024-2029) & (US$/Ton)
Table 54. World GLP-1 Drug Peptide API Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World GLP-1 Drug Peptide API Production by Application (2018-2023) & (Tons)
Table 56. World GLP-1 Drug Peptide API Production by Application (2024-2029) & (Tons)
Table 57. World GLP-1 Drug Peptide API Production Value by Application (2018-2023) & (USD Million)
Table 58. World GLP-1 Drug Peptide API Production Value by Application (2024-2029) & (USD Million)
Table 59. World GLP-1 Drug Peptide API Average Price by Application (2018-2023) & (US$/Ton)
Table 60. World GLP-1 Drug Peptide API Average Price by Application (2024-2029) & (US$/Ton)
Table 61. CPC Scientific Basic Information, Manufacturing Base and Competitors
Table 62. CPC Scientific Major Business
Table 63. CPC Scientific GLP-1 Drug Peptide API Product and Services
Table 64. CPC Scientific GLP-1 Drug Peptide API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. CPC Scientific Recent Developments/Updates
Table 66. CPC Scientific Competitive Strengths & Weaknesses
Table 67. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 68. Novo Nordisk Major Business
Table 69. Novo Nordisk GLP-1 Drug Peptide API Product and Services
Table 70. Novo Nordisk GLP-1 Drug Peptide API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Novo Nordisk Recent Developments/Updates
Table 72. Novo Nordisk Competitive Strengths & Weaknesses
Table 73. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 74. Teva Pharmaceutical Industries Ltd Major Business
Table 75. Teva Pharmaceutical Industries Ltd GLP-1 Drug Peptide API Product and Services
Table 76. Teva Pharmaceutical Industries Ltd GLP-1 Drug Peptide API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 78. Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 79. JYMedtech Basic Information, Manufacturing Base and Competitors
Table 80. JYMedtech Major Business
Table 81. JYMedtech GLP-1 Drug Peptide API Product and Services
Table 82. JYMedtech GLP-1 Drug Peptide API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. JYMedtech Recent Developments/Updates
Table 84. JYMedtech Competitive Strengths & Weaknesses
Table 85. Zhejiang Peptites Biotech Basic Information, Manufacturing Base and Competitors
Table 86. Zhejiang Peptites Biotech Major Business
Table 87. Zhejiang Peptites Biotech GLP-1 Drug Peptide API Product and Services
Table 88. Zhejiang Peptites Biotech GLP-1 Drug Peptide API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Zhejiang Peptites Biotech Recent Developments/Updates
Table 90. Zhejiang Peptites Biotech Competitive Strengths & Weaknesses
Table 91. Shengnuo Biotechnology Basic Information, Manufacturing Base and Competitors
Table 92. Shengnuo Biotechnology Major Business
Table 93. Shengnuo Biotechnology GLP-1 Drug Peptide API Product and Services
Table 94. Shengnuo Biotechnology GLP-1 Drug Peptide API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Shengnuo Biotechnology Recent Developments/Updates
Table 96. Shengnuo Biotechnology Competitive Strengths & Weaknesses
Table 97. Suzhou Tianma Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 98. Suzhou Tianma Pharmaceutical Major Business
Table 99. Suzhou Tianma Pharmaceutical GLP-1 Drug Peptide API Product and Services
Table 100. Suzhou Tianma Pharmaceutical GLP-1 Drug Peptide API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Suzhou Tianma Pharmaceutical Recent Developments/Updates
Table 102. Suzhou Tianma Pharmaceutical Competitive Strengths & Weaknesses
Table 103. SINOPEP Basic Information, Manufacturing Base and Competitors
Table 104. SINOPEP Major Business
Table 105. SINOPEP GLP-1 Drug Peptide API Product and Services
Table 106. SINOPEP GLP-1 Drug Peptide API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. SINOPEP Recent Developments/Updates
Table 108. SINOPEP Competitive Strengths & Weaknesses
Table 109. WuXi AppTec Basic Information, Manufacturing Base and Competitors
Table 110. WuXi AppTec Major Business
Table 111. WuXi AppTec GLP-1 Drug Peptide API Product and Services
Table 112. WuXi AppTec GLP-1 Drug Peptide API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. WuXi AppTec Recent Developments/Updates
Table 114. HYBIO Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 115. HYBIO Pharmaceutical Major Business
Table 116. HYBIO Pharmaceutical GLP-1 Drug Peptide API Product and Services
Table 117. HYBIO Pharmaceutical GLP-1 Drug Peptide API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of GLP-1 Drug Peptide API Upstream (Raw Materials)
Table 119. GLP-1 Drug Peptide API Typical Customers
Table 120. GLP-1 Drug Peptide API Typical Distributors
LIST OF FIGURE
Figure 1. GLP-1 Drug Peptide API Picture
Figure 2. World GLP-1 Drug Peptide API Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World GLP-1 Drug Peptide API Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World GLP-1 Drug Peptide API Production (2018-2029) & (Tons)
Figure 5. World GLP-1 Drug Peptide API Average Price (2018-2029) & (US$/Ton)
Figure 6. World GLP-1 Drug Peptide API Production Value Market Share by Region (2018-2029)
Figure 7. World GLP-1 Drug Peptide API Production Market Share by Region (2018-2029)
Figure 8. North America GLP-1 Drug Peptide API Production (2018-2029) & (Tons)
Figure 9. Europe GLP-1 Drug Peptide API Production (2018-2029) & (Tons)
Figure 10. China GLP-1 Drug Peptide API Production (2018-2029) & (Tons)
Figure 11. Japan GLP-1 Drug Peptide API Production (2018-2029) & (Tons)
Figure 12. GLP-1 Drug Peptide API Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World GLP-1 Drug Peptide API Consumption (2018-2029) & (Tons)
Figure 15. World GLP-1 Drug Peptide API Consumption Market Share by Region (2018-2029)
Figure 16. United States GLP-1 Drug Peptide API Consumption (2018-2029) & (Tons)
Figure 17. China GLP-1 Drug Peptide API Consumption (2018-2029) & (Tons)
Figure 18. Europe GLP-1 Drug Peptide API Consumption (2018-2029) & (Tons)
Figure 19. Japan GLP-1 Drug Peptide API Consumption (2018-2029) & (Tons)
Figure 20. South Korea GLP-1 Drug Peptide API Consumption (2018-2029) & (Tons)
Figure 21. ASEAN GLP-1 Drug Peptide API Consumption (2018-2029) & (Tons)
Figure 22. India GLP-1 Drug Peptide API Consumption (2018-2029) & (Tons)
Figure 23. Producer Shipments of GLP-1 Drug Peptide API by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for GLP-1 Drug Peptide API Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for GLP-1 Drug Peptide API Markets in 2022
Figure 26. United States VS China: GLP-1 Drug Peptide API Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: GLP-1 Drug Peptide API Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: GLP-1 Drug Peptide API Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers GLP-1 Drug Peptide API Production Market Share 2022
Figure 30. China Based Manufacturers GLP-1 Drug Peptide API Production Market Share 2022
Figure 31. Rest of World Based Manufacturers GLP-1 Drug Peptide API Production Market Share 2022
Figure 32. World GLP-1 Drug Peptide API Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World GLP-1 Drug Peptide API Production Value Market Share by Type in 2022
Figure 34. Semaglutide
Figure 35. Liraglutide
Figure 36. Tilpotide
Figure 37. World GLP-1 Drug Peptide API Production Market Share by Type (2018-2029)
Figure 38. World GLP-1 Drug Peptide API Production Value Market Share by Type (2018-2029)
Figure 39. World GLP-1 Drug Peptide API Average Price by Type (2018-2029) & (US$/Ton)
Figure 40. World GLP-1 Drug Peptide API Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World GLP-1 Drug Peptide API Production Value Market Share by Application in 2022
Figure 42. Diabetes
Figure 43. Obesity
Figure 44. Other
Figure 45. World GLP-1 Drug Peptide API Production Market Share by Application (2018-2029)
Figure 46. World GLP-1 Drug Peptide API Production Value Market Share by Application (2018-2029)
Figure 47. World GLP-1 Drug Peptide API Average Price by Application (2018-2029) & (US$/Ton)
Figure 48. GLP-1 Drug Peptide API Industry Chain
Figure 49. GLP-1 Drug Peptide API Procurement Model
Figure 50. GLP-1 Drug Peptide API Sales Model
Figure 51. GLP-1 Drug Peptide API Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Table 1. World GLP-1 Drug Peptide API Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World GLP-1 Drug Peptide API Production Value by Region (2018-2023) & (USD Million)
Table 3. World GLP-1 Drug Peptide API Production Value by Region (2024-2029) & (USD Million)
Table 4. World GLP-1 Drug Peptide API Production Value Market Share by Region (2018-2023)
Table 5. World GLP-1 Drug Peptide API Production Value Market Share by Region (2024-2029)
Table 6. World GLP-1 Drug Peptide API Production by Region (2018-2023) & (Tons)
Table 7. World GLP-1 Drug Peptide API Production by Region (2024-2029) & (Tons)
Table 8. World GLP-1 Drug Peptide API Production Market Share by Region (2018-2023)
Table 9. World GLP-1 Drug Peptide API Production Market Share by Region (2024-2029)
Table 10. World GLP-1 Drug Peptide API Average Price by Region (2018-2023) & (US$/Ton)
Table 11. World GLP-1 Drug Peptide API Average Price by Region (2024-2029) & (US$/Ton)
Table 12. GLP-1 Drug Peptide API Major Market Trends
Table 13. World GLP-1 Drug Peptide API Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (Tons)
Table 14. World GLP-1 Drug Peptide API Consumption by Region (2018-2023) & (Tons)
Table 15. World GLP-1 Drug Peptide API Consumption Forecast by Region (2024-2029) & (Tons)
Table 16. World GLP-1 Drug Peptide API Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key GLP-1 Drug Peptide API Producers in 2022
Table 18. World GLP-1 Drug Peptide API Production by Manufacturer (2018-2023) & (Tons)
Table 19. Production Market Share of Key GLP-1 Drug Peptide API Producers in 2022
Table 20. World GLP-1 Drug Peptide API Average Price by Manufacturer (2018-2023) & (US$/Ton)
Table 21. Global GLP-1 Drug Peptide API Company Evaluation Quadrant
Table 22. World GLP-1 Drug Peptide API Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and GLP-1 Drug Peptide API Production Site of Key Manufacturer
Table 24. GLP-1 Drug Peptide API Market: Company Product Type Footprint
Table 25. GLP-1 Drug Peptide API Market: Company Product Application Footprint
Table 26. GLP-1 Drug Peptide API Competitive Factors
Table 27. GLP-1 Drug Peptide API New Entrant and Capacity Expansion Plans
Table 28. GLP-1 Drug Peptide API Mergers & Acquisitions Activity
Table 29. United States VS China GLP-1 Drug Peptide API Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China GLP-1 Drug Peptide API Production Comparison, (2018 & 2022 & 2029) & (Tons)
Table 31. United States VS China GLP-1 Drug Peptide API Consumption Comparison, (2018 & 2022 & 2029) & (Tons)
Table 32. United States Based GLP-1 Drug Peptide API Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers GLP-1 Drug Peptide API Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers GLP-1 Drug Peptide API Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers GLP-1 Drug Peptide API Production (2018-2023) & (Tons)
Table 36. United States Based Manufacturers GLP-1 Drug Peptide API Production Market Share (2018-2023)
Table 37. China Based GLP-1 Drug Peptide API Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers GLP-1 Drug Peptide API Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers GLP-1 Drug Peptide API Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers GLP-1 Drug Peptide API Production (2018-2023) & (Tons)
Table 41. China Based Manufacturers GLP-1 Drug Peptide API Production Market Share (2018-2023)
Table 42. Rest of World Based GLP-1 Drug Peptide API Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers GLP-1 Drug Peptide API Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers GLP-1 Drug Peptide API Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers GLP-1 Drug Peptide API Production (2018-2023) & (Tons)
Table 46. Rest of World Based Manufacturers GLP-1 Drug Peptide API Production Market Share (2018-2023)
Table 47. World GLP-1 Drug Peptide API Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World GLP-1 Drug Peptide API Production by Type (2018-2023) & (Tons)
Table 49. World GLP-1 Drug Peptide API Production by Type (2024-2029) & (Tons)
Table 50. World GLP-1 Drug Peptide API Production Value by Type (2018-2023) & (USD Million)
Table 51. World GLP-1 Drug Peptide API Production Value by Type (2024-2029) & (USD Million)
Table 52. World GLP-1 Drug Peptide API Average Price by Type (2018-2023) & (US$/Ton)
Table 53. World GLP-1 Drug Peptide API Average Price by Type (2024-2029) & (US$/Ton)
Table 54. World GLP-1 Drug Peptide API Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World GLP-1 Drug Peptide API Production by Application (2018-2023) & (Tons)
Table 56. World GLP-1 Drug Peptide API Production by Application (2024-2029) & (Tons)
Table 57. World GLP-1 Drug Peptide API Production Value by Application (2018-2023) & (USD Million)
Table 58. World GLP-1 Drug Peptide API Production Value by Application (2024-2029) & (USD Million)
Table 59. World GLP-1 Drug Peptide API Average Price by Application (2018-2023) & (US$/Ton)
Table 60. World GLP-1 Drug Peptide API Average Price by Application (2024-2029) & (US$/Ton)
Table 61. CPC Scientific Basic Information, Manufacturing Base and Competitors
Table 62. CPC Scientific Major Business
Table 63. CPC Scientific GLP-1 Drug Peptide API Product and Services
Table 64. CPC Scientific GLP-1 Drug Peptide API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. CPC Scientific Recent Developments/Updates
Table 66. CPC Scientific Competitive Strengths & Weaknesses
Table 67. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 68. Novo Nordisk Major Business
Table 69. Novo Nordisk GLP-1 Drug Peptide API Product and Services
Table 70. Novo Nordisk GLP-1 Drug Peptide API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Novo Nordisk Recent Developments/Updates
Table 72. Novo Nordisk Competitive Strengths & Weaknesses
Table 73. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 74. Teva Pharmaceutical Industries Ltd Major Business
Table 75. Teva Pharmaceutical Industries Ltd GLP-1 Drug Peptide API Product and Services
Table 76. Teva Pharmaceutical Industries Ltd GLP-1 Drug Peptide API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 78. Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 79. JYMedtech Basic Information, Manufacturing Base and Competitors
Table 80. JYMedtech Major Business
Table 81. JYMedtech GLP-1 Drug Peptide API Product and Services
Table 82. JYMedtech GLP-1 Drug Peptide API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. JYMedtech Recent Developments/Updates
Table 84. JYMedtech Competitive Strengths & Weaknesses
Table 85. Zhejiang Peptites Biotech Basic Information, Manufacturing Base and Competitors
Table 86. Zhejiang Peptites Biotech Major Business
Table 87. Zhejiang Peptites Biotech GLP-1 Drug Peptide API Product and Services
Table 88. Zhejiang Peptites Biotech GLP-1 Drug Peptide API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Zhejiang Peptites Biotech Recent Developments/Updates
Table 90. Zhejiang Peptites Biotech Competitive Strengths & Weaknesses
Table 91. Shengnuo Biotechnology Basic Information, Manufacturing Base and Competitors
Table 92. Shengnuo Biotechnology Major Business
Table 93. Shengnuo Biotechnology GLP-1 Drug Peptide API Product and Services
Table 94. Shengnuo Biotechnology GLP-1 Drug Peptide API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Shengnuo Biotechnology Recent Developments/Updates
Table 96. Shengnuo Biotechnology Competitive Strengths & Weaknesses
Table 97. Suzhou Tianma Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 98. Suzhou Tianma Pharmaceutical Major Business
Table 99. Suzhou Tianma Pharmaceutical GLP-1 Drug Peptide API Product and Services
Table 100. Suzhou Tianma Pharmaceutical GLP-1 Drug Peptide API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Suzhou Tianma Pharmaceutical Recent Developments/Updates
Table 102. Suzhou Tianma Pharmaceutical Competitive Strengths & Weaknesses
Table 103. SINOPEP Basic Information, Manufacturing Base and Competitors
Table 104. SINOPEP Major Business
Table 105. SINOPEP GLP-1 Drug Peptide API Product and Services
Table 106. SINOPEP GLP-1 Drug Peptide API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. SINOPEP Recent Developments/Updates
Table 108. SINOPEP Competitive Strengths & Weaknesses
Table 109. WuXi AppTec Basic Information, Manufacturing Base and Competitors
Table 110. WuXi AppTec Major Business
Table 111. WuXi AppTec GLP-1 Drug Peptide API Product and Services
Table 112. WuXi AppTec GLP-1 Drug Peptide API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. WuXi AppTec Recent Developments/Updates
Table 114. HYBIO Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 115. HYBIO Pharmaceutical Major Business
Table 116. HYBIO Pharmaceutical GLP-1 Drug Peptide API Product and Services
Table 117. HYBIO Pharmaceutical GLP-1 Drug Peptide API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of GLP-1 Drug Peptide API Upstream (Raw Materials)
Table 119. GLP-1 Drug Peptide API Typical Customers
Table 120. GLP-1 Drug Peptide API Typical Distributors
LIST OF FIGURE
Figure 1. GLP-1 Drug Peptide API Picture
Figure 2. World GLP-1 Drug Peptide API Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World GLP-1 Drug Peptide API Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World GLP-1 Drug Peptide API Production (2018-2029) & (Tons)
Figure 5. World GLP-1 Drug Peptide API Average Price (2018-2029) & (US$/Ton)
Figure 6. World GLP-1 Drug Peptide API Production Value Market Share by Region (2018-2029)
Figure 7. World GLP-1 Drug Peptide API Production Market Share by Region (2018-2029)
Figure 8. North America GLP-1 Drug Peptide API Production (2018-2029) & (Tons)
Figure 9. Europe GLP-1 Drug Peptide API Production (2018-2029) & (Tons)
Figure 10. China GLP-1 Drug Peptide API Production (2018-2029) & (Tons)
Figure 11. Japan GLP-1 Drug Peptide API Production (2018-2029) & (Tons)
Figure 12. GLP-1 Drug Peptide API Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World GLP-1 Drug Peptide API Consumption (2018-2029) & (Tons)
Figure 15. World GLP-1 Drug Peptide API Consumption Market Share by Region (2018-2029)
Figure 16. United States GLP-1 Drug Peptide API Consumption (2018-2029) & (Tons)
Figure 17. China GLP-1 Drug Peptide API Consumption (2018-2029) & (Tons)
Figure 18. Europe GLP-1 Drug Peptide API Consumption (2018-2029) & (Tons)
Figure 19. Japan GLP-1 Drug Peptide API Consumption (2018-2029) & (Tons)
Figure 20. South Korea GLP-1 Drug Peptide API Consumption (2018-2029) & (Tons)
Figure 21. ASEAN GLP-1 Drug Peptide API Consumption (2018-2029) & (Tons)
Figure 22. India GLP-1 Drug Peptide API Consumption (2018-2029) & (Tons)
Figure 23. Producer Shipments of GLP-1 Drug Peptide API by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for GLP-1 Drug Peptide API Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for GLP-1 Drug Peptide API Markets in 2022
Figure 26. United States VS China: GLP-1 Drug Peptide API Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: GLP-1 Drug Peptide API Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: GLP-1 Drug Peptide API Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers GLP-1 Drug Peptide API Production Market Share 2022
Figure 30. China Based Manufacturers GLP-1 Drug Peptide API Production Market Share 2022
Figure 31. Rest of World Based Manufacturers GLP-1 Drug Peptide API Production Market Share 2022
Figure 32. World GLP-1 Drug Peptide API Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World GLP-1 Drug Peptide API Production Value Market Share by Type in 2022
Figure 34. Semaglutide
Figure 35. Liraglutide
Figure 36. Tilpotide
Figure 37. World GLP-1 Drug Peptide API Production Market Share by Type (2018-2029)
Figure 38. World GLP-1 Drug Peptide API Production Value Market Share by Type (2018-2029)
Figure 39. World GLP-1 Drug Peptide API Average Price by Type (2018-2029) & (US$/Ton)
Figure 40. World GLP-1 Drug Peptide API Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World GLP-1 Drug Peptide API Production Value Market Share by Application in 2022
Figure 42. Diabetes
Figure 43. Obesity
Figure 44. Other
Figure 45. World GLP-1 Drug Peptide API Production Market Share by Application (2018-2029)
Figure 46. World GLP-1 Drug Peptide API Production Value Market Share by Application (2018-2029)
Figure 47. World GLP-1 Drug Peptide API Average Price by Application (2018-2029) & (US$/Ton)
Figure 48. GLP-1 Drug Peptide API Industry Chain
Figure 49. GLP-1 Drug Peptide API Procurement Model
Figure 50. GLP-1 Drug Peptide API Sales Model
Figure 51. GLP-1 Drug Peptide API Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
